Jamaica PottsSzeliga
Partner
Intellectual Property
anN6ZWxpZ2FAc2V5ZmFydGguY29t

Jamaica is an intellectual property attorney, focusing on IP litigation, patent prosecution, and corporate IP matters.
More About Jamaica
For more than 20 years, Jamaica has practiced intellectual property law—litigating cases, obtaining and managing patents, and assisting with corporate matters that have a heavy IP focus.
Jamaica’s practice is wide ranging and includes patent and trade secret litigation, utility and design patent prosecution, corporate work, and regulatory advice. Her focus is on providing clients and their companies with the legal assistance they need to protect, enforce, and commercialize their inventions and innovations.
- Litigation: Jamaica litigates utility patent disputes as well as cases involving design patents, trade secrets, and contract claims relating to complex technologies. Her cases have spanned from biotechnology, telecommunications, and medical devices to home goods, food and beverage, accessories, and toys. She has experience before multiple district courts and the Patent Trial and Appeal Board in both post-grant reviews (PGRs) and inter partes review (IPR) proceedings, and has both briefed and argued cases before the Federal Circuit and Fourth Circuit. With a degree in chemistry and biology, Jamaica also has represented both pharmaceutical and generic companies in Hatch-Waxman patent litigation, as well as advised companies on the Biologics Price Competition and Innovation Act.
- Prosecution: Jamaica is a member of the USPTO patent bar. She helps inventors obtain and manage their utility and design inventions in multiple technological and design-oriented areas. This includes, for example, filing and pursuing patent applications on mechanical inventions, digital health, and professional services, and also protecting innovations in home goods, fashion, material science, and food.
- Corporate: As an IP attorney, Jamaica helps her corporate colleagues with business contracts and corporate deals where IP is an important component. This includes drafting and revising NDAs, license agreements, development agreements, master services agreements, and supplier and vendor agreements, among others. She also assists with joint ventures, mergers and acquisitions, and divestitures. Jamaica, further, is a member of Seyfarth’s Transactional Risk Insurance team, providing general overviews for certain deals and handling IP, IT, and data privacy issues arising in M&A deals using representations and warranties insurance (RWI).
- Regulatory: With respect to medical and veterinary devices, Jamaica advises on FDA compliance, particularly concerning marketing and promotional materials. She recently became the co-host of Seyfarth’s Health Care Beat Podcast series. Of note, throughout the pandemic, Jamaica drafted more than two dozen blogs and articles focused on FDA and CDC responses to COVID-19.
Jamaica recently was listed in Women We Admire’s "Top 50 Women Leaders in Law of 2022." Women We Admire provides news and information on today's women leaders in business, entertainment, sports, motherhood, medicine, law, and many other fields.
Jamaica’s practice is wide ranging and includes patent and trade secret litigation, utility and design patent prosecution, corporate work, and regulatory advice. Her focus is on providing clients and their companies with the legal assistance they need to protect, enforce, and commercialize their inventions and innovations.
- Litigation: Jamaica litigates utility patent disputes as well as cases involving design patents, trade secrets, and contract claims relating to complex technologies. Her cases have spanned from biotechnology, telecommunications, and medical devices to home goods, food and beverage, accessories, and toys. She has experience before multiple district courts and the Patent Trial and Appeal Board in both post-grant reviews (PGRs) and inter partes review (IPR) proceedings, and has both briefed and argued cases before the Federal Circuit and Fourth Circuit. With a degree in chemistry and biology, Jamaica also has represented both pharmaceutical and generic companies in Hatch-Waxman patent litigation, as well as advised companies on the Biologics Price Competition and Innovation Act.
- Prosecution: Jamaica is a member of the USPTO patent bar. She helps inventors obtain and manage their utility and design inventions in multiple technological and design-oriented areas. This includes, for example, filing and pursuing patent applications on mechanical inventions, digital health, and professional services, and also protecting innovations in home goods, fashion, material science, and food.
- Corporate: As an IP attorney, Jamaica helps her corporate colleagues with business contracts and corporate deals where IP is an important component. This includes drafting and revising NDAs, license agreements, development agreements, master services agreements, and supplier and vendor agreements, among others. She also assists with joint ventures, mergers and acquisitions, and divestitures. Jamaica, further, is a member of Seyfarth’s Transactional Risk Insurance team, providing general overviews for certain deals and handling IP, IT, and data privacy issues arising in M&A deals using representations and warranties insurance (RWI).
- Regulatory: With respect to medical and veterinary devices, Jamaica advises on FDA compliance, particularly concerning marketing and promotional materials. She recently became the co-host of Seyfarth’s Health Care Beat Podcast series. Of note, throughout the pandemic, Jamaica drafted more than two dozen blogs and articles focused on FDA and CDC responses to COVID-19.
Jamaica recently was listed in Women We Admire’s "Top 50 Women Leaders in Law of 2022." Women We Admire provides news and information on today's women leaders in business, entertainment, sports, motherhood, medicine, law, and many other fields.
- JD, Harvard Law School
Magna cum laude
- BS, Stanford University
ChemistryWith distinction
Minor in Biology
- District of Columbia
- New York
- United States Patent and Trademark Office - Registered Patent Attorney
- US Supreme Court
- US Court of Appeals, Fourth Circuit
- US Court of Appeals, Federal Circuit
- District of Columbia Court of Appeals
- New York Court of Appeals
Related News & Insights
-
Podcast
Aug 30, 2023
Health Care Beat Episode 41 – Insuring Success: The Utilization of Insurance in Health Care M&A Transactions
-
Podcast
Aug 3, 2023
Health Care Beat Episode 40: US Digital Health Series – Payment & Reimbursement
-
Podcast
Jun 30, 2023
Health Care Beat Episode 39: US Digital Health Series – Advertising, Marketing, and E-Commerce
-
Podcast
Jun 1, 2023
Health Care Beat Episode 38: US Digital Health Series – Data Protection and Management
- Listed among “Top 50 Women Leaders in Law of 2022” by Women We Admire (2022)
- Listed in Washington, DC Super Lawyers “Rising Stars” for Intellectual Property Litigation (Thomson Reuters) (2016-2017)
- American Bar Association
- The Federal Circuit Bar Association
- The American Chemical Society
- The Washington Area Lawyers for the Arts
- Co-Author, "Seyfarth Shaw IP Team Files Supreme Court Amici Brief in Trade Dress Case," Legal Update, Seyfarth Shaw LLP (October 28, 2021)
- Co-Author, "FDA Issues Emergency Use Authorization for COVID-19 Vaccine," Legal Update, Seyfarth Shaw LLP (December 14, 2020)
- Co-Author, "FDA Approves Veklury (remdesivir) As The First Treatment For COVID-19," Legal Update, Seyfarth Shaw LLP (October 26, 2020)
- Co-Author, "Chinese Manufacturers of Personal Protective Equipment Gave False U.S. Agent Information to Food and Drug Administration," Legal Update, Seyfarth Shaw LLP (June 24, 2020)
- Co-Author, "FDA Revokes Emergency Use Authorization For Highly Watched Chloroquine and Hydroxychloroquine - But They Can Still Be Prescribed," Legal Update, Seyfarth Shaw LLP (June 18, 2020)
- Co-Author, "FDA Revises Guidance on Face Masks, Respirators, and Face Shields to Address Covid-19 Concerns," Legal Update, Seyfarth Shaw LLP (May 29, 2020)
- Co-Author, "FDA Updates Emergency Use Authorization For Chinese Respirators," Legal Update, Seyfarth Shaw LLP (May 8, 2020)
- Co-Author, "Small and Micro Businesses Alert: USPTO Announces Program for Applications Covering Prevention and Treatment of COVID-19," Legal Update, Seyfarth Shaw LLP (May 8, 2020)
- Co-Author, "FDA Collection and Labeling Protocols For Use of Convalescent Plasma As A Treatment for COVID-19," Legal Update, Seyfarth Shaw LLP (April 28, 2020)
- Co-Author, "FDA Provides Safety Communication Relating to Use of Antimalarial Drugs Hydroxychloroquine and Chloroquine In the Treatment of COVID-19," Legal Update, Seyfarth Shaw LLP (April 28, 2020)
- Co-Author, "FDA Provides Guidance on How to Request Authorization to Use Convalescent Plasma as a Treatment for COVID-19," Legal Update, Seyfarth Shaw LLP (April 27, 2020)
- Co-Author, "FDA Authorizes Synthetic Nasal Swab to Increase COVID-19 Testing," Legal Update, Seyfarth Shaw LLP (April 22, 2020)
- Co-Author, "Guide For General Public: FDA Explains How Everyone Can “Make a Difference” During COVID-19 With Simple Infographic, Update," Legal Update, Seyfarth Shaw LLP (April 21, 2020)
- Co-Author, "FDA and NCI to Review COVID-19 Antibody Tests Marketed Under FDA Guidance Permitting Sale Without FDA Authorization," Legal Update, Seyfarth Shaw LLP (April 17, 2020)
- Co-Author, "Head to Toe: Summary of FDA COVID-19 Guidance Relating to Gowns, Other Apparel, and Gloves," Legal Update, Seyfarth Shaw LLP (April 13, 2020)
- Co-Author, "FDA Announces the Creation of CTAP—Coronavirus Treatment Acceleration Program—to Assist Drug Developers and Evaluators," Legal Update, Seyfarth Shaw LLP (April 10, 2020)
- Co-Author, "FDA Issues Updated Guidance Relating to its Enforcement Policy for Face Masks and Respirators," Legal Update, Seyfarth Shaw LLP (April 8, 2020)
- Co-Author, "CDC Provides Recommendations for Respirators When N95 Respirators Are Not Available in COVID-19 Crisis," Legal Update, Seyfarth Shaw LLP (April 7, 2020)
- Co-Author, "FDA Issues Guidance Documents Directed to Blood Donations as Part of COVID-19 Public Health Emergency Measures," Legal Update, Seyfarth Shaw LLP (April 3, 2020)
- Co-Author, "FDA Issues Guidance Regarding Alcohol-Based Hand Sanitizers For COVID-19 Prevention," Legal Update, Seyfarth Shaw LLP (April 3, 2020)
- Co-Author, "USPTO Extends Certain Patent-Related Timing Deadlines," Legal Update, Seyfarth Shaw LLP (April 3, 2020)
- Co-Author, "FDA Emergency Use Authorizations ('EUA') for COVID-19: What is an EUA and What is Currently Covered?," Legal Update, Seyfarth Shaw LLP (April 2, 2020)
- Co-Author, "FDA Eases Enforcement to Expand Remote Care of Pets and Food-Producing Animals," Legal Update, Seyfarth Shaw LLP (April 1, 2020)
- Co-Author, "FDA Eases Enforcement to Help Make More Ventilators Available," Legal Update, Seyfarth Shaw LLP (March 27, 2020)
- Co-Author, "False Advertising: Changing Your Business To Meet Market Needs During The COVID-19 Pandemic," Legal Update, Seyfarth Shaw LLP (March 25, 2020)
- Co-Author, "The USPTO Considers the Effects of the Coronavirus Outbreak to be an 'Extraordinary Situation:' What That Means for Trademark Applicants and Trademark Owners," Legal Update, Seyfarth Shaw LLP (March 21, 2020)
- Co-Author, "The USPTO Considers the Effects of the Coronavirus Outbreak to be an 'Extraordinary Situation:' What That Means for Patent Applicants and Patent Owners," Legal Update, Seyfarth Shaw LLP (March 20, 2020)
- "Sandoz v. Amgen: The Latest in Biosimilar ‘Dances’," BioLoquitur, Seyfarth Shaw LLP (June 28, 2017)
- "Sandoz v. Amgen: Supreme Court Nixes Post-Approval Waiting Period for Biosimilars," Client Alert, Seyfarth Shaw LLP (June 15, 2017)
- "High Court Limits Where Patent Suits Can Be Filed," One Minute Memo, Seyfarth Shaw LLP (May 31, 2017)
- "Venue in ANDA Litigation: Will TC Heartland Be a Sea Change or Just a Drop in the Bucket?," BioLoquitur, Seyfarth Shaw LLP (May 26, 2017)
- "Legislative Overview: First Quarter 2017,” BioLoquitur, Seyfarth Shaw LLP (April 14, 2017)
- Co-Author, "2008 Patent Law Decisions of the Federal Circuit," 58 American University Law Review 747 (2009)
- Co-Author, "Not So Fast: The Sealed Air Asbestos Settlement and Methods of Risk Management in the Acquisition of Companies with Asbestos Liabilities," 11 New York University Environmental Law Journal 626 (2003)
- Co-Author, "Proposed Rule Changes to Federal Civil Procedure May Introduce New Challenges in Environmental Class Action Litigation," 27 Harvard Environmental Law Review 519 (2003)
- "At Least Give the Natives Glass Beads: An Examination of the Bargain Made between Iceland and deCODE Genetics with Implications for Global Bioprospecting," 7 Virginia Journal of Law and Technology 8 (2002)
- Co-Speaker, "Health Care Beat Episode 41 – Insuring Success: The Utilization of Insurance in Health Care M&A Transactions," Podcast, Seyfarth Shaw LLP (August 30, 2023)
- Co-Speaker, "Health Care Beat Episode 40: US Digital Health Series – Payment & Reimbursement," Podcast, Seyfarth Shaw LLP (August 3, 2023)
-
Co-Presenter, "Health Care Beat Episode 39: US Digital Health Series – Advertising, Marketing, and E-Commerce," Podcast, Seyfarth Shaw LLP (June 30, 2023)
- Co-Speaker, "Health Care Beat Episode 38: US Digital Health Series – Data Protection and Management," Podcast, Seyfarth Shaw LLP (June 1, 2023)
- Co-Speaker, "Health Care Beat Episode 37: Labor Relations in Health Care – What to Expect at the Bargaining Table and From the NLRB in 2023," Podcast, Seyfarth Shaw LLP (May 16, 2023)
- Co-presenter on US IP Law to delegation of IP professionals from Bosnia and Herzegovinia at the request of the Department of Commerce.
- Co-Presenter, "Health Care Beat Episode 36: US Digital Health Series – Transactional Issues," Podcast, Seyfarth Shaw LLP (April 26, 2023)
- Co-Speaker, "Health Care Beat Episode 35: US Digital Health Series – Intellectual Property," Podcast, Seyfarth Shaw LLP (April 4, 2023)
- Speaker, Health Care Beat Podcast: Episode 12: COVID-19 Vaccines Are Here: Now What?, Seyfarth Shaw LLP (August 5, 2021)
- "Trends in Paragraph IV Challenges: What Lies Ahead in 2017 and Beyond," presented by The Knowledge Group (May 24, 2017)
- "The BPCIA Patent Dance - What Biosimilar Companies Need to Know," presented by The Knowledge Group (January 10, 2017)
- "USPTO’s Proposed Changes to AIA Post-Grant Amendment Proceedings: Preparing for the Big Shift," presented by The Knowledge Group (March 29, 2016)
Jamaica is an intellectual property attorney, focusing on IP litigation, patent prosecution, and corporate IP matters.
More About Jamaica
For more than 20 years, Jamaica has practiced intellectual property law—litigating cases, obtaining and managing patents, and assisting with corporate matters that have a heavy IP focus.
Jamaica’s practice is wide ranging and includes patent and trade secret litigation, utility and design patent prosecution, corporate work, and regulatory advice. Her focus is on providing clients and their companies with the legal assistance they need to protect, enforce, and commercialize their inventions and innovations.
- Litigation: Jamaica litigates utility patent disputes as well as cases involving design patents, trade secrets, and contract claims relating to complex technologies. Her cases have spanned from biotechnology, telecommunications, and medical devices to home goods, food and beverage, accessories, and toys. She has experience before multiple district courts and the Patent Trial and Appeal Board in both post-grant reviews (PGRs) and inter partes review (IPR) proceedings, and has both briefed and argued cases before the Federal Circuit and Fourth Circuit. With a degree in chemistry and biology, Jamaica also has represented both pharmaceutical and generic companies in Hatch-Waxman patent litigation, as well as advised companies on the Biologics Price Competition and Innovation Act.
- Prosecution: Jamaica is a member of the USPTO patent bar. She helps inventors obtain and manage their utility and design inventions in multiple technological and design-oriented areas. This includes, for example, filing and pursuing patent applications on mechanical inventions, digital health, and professional services, and also protecting innovations in home goods, fashion, material science, and food.
- Corporate: As an IP attorney, Jamaica helps her corporate colleagues with business contracts and corporate deals where IP is an important component. This includes drafting and revising NDAs, license agreements, development agreements, master services agreements, and supplier and vendor agreements, among others. She also assists with joint ventures, mergers and acquisitions, and divestitures. Jamaica, further, is a member of Seyfarth’s Transactional Risk Insurance team, providing general overviews for certain deals and handling IP, IT, and data privacy issues arising in M&A deals using representations and warranties insurance (RWI).
- Regulatory: With respect to medical and veterinary devices, Jamaica advises on FDA compliance, particularly concerning marketing and promotional materials. She recently became the co-host of Seyfarth’s Health Care Beat Podcast series. Of note, throughout the pandemic, Jamaica drafted more than two dozen blogs and articles focused on FDA and CDC responses to COVID-19.
Jamaica recently was listed in Women We Admire’s "Top 50 Women Leaders in Law of 2022." Women We Admire provides news and information on today's women leaders in business, entertainment, sports, motherhood, medicine, law, and many other fields.
Jamaica’s practice is wide ranging and includes patent and trade secret litigation, utility and design patent prosecution, corporate work, and regulatory advice. Her focus is on providing clients and their companies with the legal assistance they need to protect, enforce, and commercialize their inventions and innovations.
- Litigation: Jamaica litigates utility patent disputes as well as cases involving design patents, trade secrets, and contract claims relating to complex technologies. Her cases have spanned from biotechnology, telecommunications, and medical devices to home goods, food and beverage, accessories, and toys. She has experience before multiple district courts and the Patent Trial and Appeal Board in both post-grant reviews (PGRs) and inter partes review (IPR) proceedings, and has both briefed and argued cases before the Federal Circuit and Fourth Circuit. With a degree in chemistry and biology, Jamaica also has represented both pharmaceutical and generic companies in Hatch-Waxman patent litigation, as well as advised companies on the Biologics Price Competition and Innovation Act.
- Prosecution: Jamaica is a member of the USPTO patent bar. She helps inventors obtain and manage their utility and design inventions in multiple technological and design-oriented areas. This includes, for example, filing and pursuing patent applications on mechanical inventions, digital health, and professional services, and also protecting innovations in home goods, fashion, material science, and food.
- Corporate: As an IP attorney, Jamaica helps her corporate colleagues with business contracts and corporate deals where IP is an important component. This includes drafting and revising NDAs, license agreements, development agreements, master services agreements, and supplier and vendor agreements, among others. She also assists with joint ventures, mergers and acquisitions, and divestitures. Jamaica, further, is a member of Seyfarth’s Transactional Risk Insurance team, providing general overviews for certain deals and handling IP, IT, and data privacy issues arising in M&A deals using representations and warranties insurance (RWI).
- Regulatory: With respect to medical and veterinary devices, Jamaica advises on FDA compliance, particularly concerning marketing and promotional materials. She recently became the co-host of Seyfarth’s Health Care Beat Podcast series. Of note, throughout the pandemic, Jamaica drafted more than two dozen blogs and articles focused on FDA and CDC responses to COVID-19.
Jamaica recently was listed in Women We Admire’s "Top 50 Women Leaders in Law of 2022." Women We Admire provides news and information on today's women leaders in business, entertainment, sports, motherhood, medicine, law, and many other fields.
- JD, Harvard Law School
Magna cum laude
- BS, Stanford University
ChemistryWith distinction
Minor in Biology
- District of Columbia
- New York
- United States Patent and Trademark Office - Registered Patent Attorney
- US Supreme Court
- US Court of Appeals, Fourth Circuit
- US Court of Appeals, Federal Circuit
- District of Columbia Court of Appeals
- New York Court of Appeals
Related News & Insights
-
Podcast
Aug 30, 2023
Health Care Beat Episode 41 – Insuring Success: The Utilization of Insurance in Health Care M&A Transactions
-
Podcast
Aug 3, 2023
Health Care Beat Episode 40: US Digital Health Series – Payment & Reimbursement
-
Podcast
Jun 30, 2023
Health Care Beat Episode 39: US Digital Health Series – Advertising, Marketing, and E-Commerce
-
Podcast
Jun 1, 2023
Health Care Beat Episode 38: US Digital Health Series – Data Protection and Management
- Listed among “Top 50 Women Leaders in Law of 2022” by Women We Admire (2022)
- Listed in Washington, DC Super Lawyers “Rising Stars” for Intellectual Property Litigation (Thomson Reuters) (2016-2017)
- American Bar Association
- The Federal Circuit Bar Association
- The American Chemical Society
- The Washington Area Lawyers for the Arts
- Co-Author, "Seyfarth Shaw IP Team Files Supreme Court Amici Brief in Trade Dress Case," Legal Update, Seyfarth Shaw LLP (October 28, 2021)
- Co-Author, "FDA Issues Emergency Use Authorization for COVID-19 Vaccine," Legal Update, Seyfarth Shaw LLP (December 14, 2020)
- Co-Author, "FDA Approves Veklury (remdesivir) As The First Treatment For COVID-19," Legal Update, Seyfarth Shaw LLP (October 26, 2020)
- Co-Author, "Chinese Manufacturers of Personal Protective Equipment Gave False U.S. Agent Information to Food and Drug Administration," Legal Update, Seyfarth Shaw LLP (June 24, 2020)
- Co-Author, "FDA Revokes Emergency Use Authorization For Highly Watched Chloroquine and Hydroxychloroquine - But They Can Still Be Prescribed," Legal Update, Seyfarth Shaw LLP (June 18, 2020)
- Co-Author, "FDA Revises Guidance on Face Masks, Respirators, and Face Shields to Address Covid-19 Concerns," Legal Update, Seyfarth Shaw LLP (May 29, 2020)
- Co-Author, "FDA Updates Emergency Use Authorization For Chinese Respirators," Legal Update, Seyfarth Shaw LLP (May 8, 2020)
- Co-Author, "Small and Micro Businesses Alert: USPTO Announces Program for Applications Covering Prevention and Treatment of COVID-19," Legal Update, Seyfarth Shaw LLP (May 8, 2020)
- Co-Author, "FDA Collection and Labeling Protocols For Use of Convalescent Plasma As A Treatment for COVID-19," Legal Update, Seyfarth Shaw LLP (April 28, 2020)
- Co-Author, "FDA Provides Safety Communication Relating to Use of Antimalarial Drugs Hydroxychloroquine and Chloroquine In the Treatment of COVID-19," Legal Update, Seyfarth Shaw LLP (April 28, 2020)
- Co-Author, "FDA Provides Guidance on How to Request Authorization to Use Convalescent Plasma as a Treatment for COVID-19," Legal Update, Seyfarth Shaw LLP (April 27, 2020)
- Co-Author, "FDA Authorizes Synthetic Nasal Swab to Increase COVID-19 Testing," Legal Update, Seyfarth Shaw LLP (April 22, 2020)
- Co-Author, "Guide For General Public: FDA Explains How Everyone Can “Make a Difference” During COVID-19 With Simple Infographic, Update," Legal Update, Seyfarth Shaw LLP (April 21, 2020)
- Co-Author, "FDA and NCI to Review COVID-19 Antibody Tests Marketed Under FDA Guidance Permitting Sale Without FDA Authorization," Legal Update, Seyfarth Shaw LLP (April 17, 2020)
- Co-Author, "Head to Toe: Summary of FDA COVID-19 Guidance Relating to Gowns, Other Apparel, and Gloves," Legal Update, Seyfarth Shaw LLP (April 13, 2020)
- Co-Author, "FDA Announces the Creation of CTAP—Coronavirus Treatment Acceleration Program—to Assist Drug Developers and Evaluators," Legal Update, Seyfarth Shaw LLP (April 10, 2020)
- Co-Author, "FDA Issues Updated Guidance Relating to its Enforcement Policy for Face Masks and Respirators," Legal Update, Seyfarth Shaw LLP (April 8, 2020)
- Co-Author, "CDC Provides Recommendations for Respirators When N95 Respirators Are Not Available in COVID-19 Crisis," Legal Update, Seyfarth Shaw LLP (April 7, 2020)
- Co-Author, "FDA Issues Guidance Documents Directed to Blood Donations as Part of COVID-19 Public Health Emergency Measures," Legal Update, Seyfarth Shaw LLP (April 3, 2020)
- Co-Author, "FDA Issues Guidance Regarding Alcohol-Based Hand Sanitizers For COVID-19 Prevention," Legal Update, Seyfarth Shaw LLP (April 3, 2020)
- Co-Author, "USPTO Extends Certain Patent-Related Timing Deadlines," Legal Update, Seyfarth Shaw LLP (April 3, 2020)
- Co-Author, "FDA Emergency Use Authorizations ('EUA') for COVID-19: What is an EUA and What is Currently Covered?," Legal Update, Seyfarth Shaw LLP (April 2, 2020)
- Co-Author, "FDA Eases Enforcement to Expand Remote Care of Pets and Food-Producing Animals," Legal Update, Seyfarth Shaw LLP (April 1, 2020)
- Co-Author, "FDA Eases Enforcement to Help Make More Ventilators Available," Legal Update, Seyfarth Shaw LLP (March 27, 2020)
- Co-Author, "False Advertising: Changing Your Business To Meet Market Needs During The COVID-19 Pandemic," Legal Update, Seyfarth Shaw LLP (March 25, 2020)
- Co-Author, "The USPTO Considers the Effects of the Coronavirus Outbreak to be an 'Extraordinary Situation:' What That Means for Trademark Applicants and Trademark Owners," Legal Update, Seyfarth Shaw LLP (March 21, 2020)
- Co-Author, "The USPTO Considers the Effects of the Coronavirus Outbreak to be an 'Extraordinary Situation:' What That Means for Patent Applicants and Patent Owners," Legal Update, Seyfarth Shaw LLP (March 20, 2020)
- "Sandoz v. Amgen: The Latest in Biosimilar ‘Dances’," BioLoquitur, Seyfarth Shaw LLP (June 28, 2017)
- "Sandoz v. Amgen: Supreme Court Nixes Post-Approval Waiting Period for Biosimilars," Client Alert, Seyfarth Shaw LLP (June 15, 2017)
- "High Court Limits Where Patent Suits Can Be Filed," One Minute Memo, Seyfarth Shaw LLP (May 31, 2017)
- "Venue in ANDA Litigation: Will TC Heartland Be a Sea Change or Just a Drop in the Bucket?," BioLoquitur, Seyfarth Shaw LLP (May 26, 2017)
- "Legislative Overview: First Quarter 2017,” BioLoquitur, Seyfarth Shaw LLP (April 14, 2017)
- Co-Author, "2008 Patent Law Decisions of the Federal Circuit," 58 American University Law Review 747 (2009)
- Co-Author, "Not So Fast: The Sealed Air Asbestos Settlement and Methods of Risk Management in the Acquisition of Companies with Asbestos Liabilities," 11 New York University Environmental Law Journal 626 (2003)
- Co-Author, "Proposed Rule Changes to Federal Civil Procedure May Introduce New Challenges in Environmental Class Action Litigation," 27 Harvard Environmental Law Review 519 (2003)
- "At Least Give the Natives Glass Beads: An Examination of the Bargain Made between Iceland and deCODE Genetics with Implications for Global Bioprospecting," 7 Virginia Journal of Law and Technology 8 (2002)
- Co-Speaker, "Health Care Beat Episode 41 – Insuring Success: The Utilization of Insurance in Health Care M&A Transactions," Podcast, Seyfarth Shaw LLP (August 30, 2023)
- Co-Speaker, "Health Care Beat Episode 40: US Digital Health Series – Payment & Reimbursement," Podcast, Seyfarth Shaw LLP (August 3, 2023)
-
Co-Presenter, "Health Care Beat Episode 39: US Digital Health Series – Advertising, Marketing, and E-Commerce," Podcast, Seyfarth Shaw LLP (June 30, 2023)
- Co-Speaker, "Health Care Beat Episode 38: US Digital Health Series – Data Protection and Management," Podcast, Seyfarth Shaw LLP (June 1, 2023)
- Co-Speaker, "Health Care Beat Episode 37: Labor Relations in Health Care – What to Expect at the Bargaining Table and From the NLRB in 2023," Podcast, Seyfarth Shaw LLP (May 16, 2023)
- Co-presenter on US IP Law to delegation of IP professionals from Bosnia and Herzegovinia at the request of the Department of Commerce.
- Co-Presenter, "Health Care Beat Episode 36: US Digital Health Series – Transactional Issues," Podcast, Seyfarth Shaw LLP (April 26, 2023)
- Co-Speaker, "Health Care Beat Episode 35: US Digital Health Series – Intellectual Property," Podcast, Seyfarth Shaw LLP (April 4, 2023)
- Speaker, Health Care Beat Podcast: Episode 12: COVID-19 Vaccines Are Here: Now What?, Seyfarth Shaw LLP (August 5, 2021)
- "Trends in Paragraph IV Challenges: What Lies Ahead in 2017 and Beyond," presented by The Knowledge Group (May 24, 2017)
- "The BPCIA Patent Dance - What Biosimilar Companies Need to Know," presented by The Knowledge Group (January 10, 2017)
- "USPTO’s Proposed Changes to AIA Post-Grant Amendment Proceedings: Preparing for the Big Shift," presented by The Knowledge Group (March 29, 2016)